The Comparative Effectiveness Evaluation of the Impact of Digital Education

NCT ID: NCT06979310

Last Updated: 2026-01-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-03-01

Study Completion Date

2028-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is being conducted to determine how best to educate caregivers about cancer and its treatment. When caregivers are well-informed, they are more confident in supporting their child through treatment, which can improve treatment adherence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pediatric Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

text-based education messages only

Group Type ACTIVE_COMPARATOR

text-based education messages only

Intervention Type OTHER

Participants will receive text-based education messages

in-clinic tablet-based multimedia education only

Group Type ACTIVE_COMPARATOR

in-clinic tablet-based multimedia education

Intervention Type OTHER

Participants will receive tablet-based multimedia education in clinic

both text-based and tablet-based digital education strategies

Group Type ACTIVE_COMPARATOR

text-based education messages only

Intervention Type OTHER

Participants will receive text-based education messages

in-clinic tablet-based multimedia education

Intervention Type OTHER

Participants will receive tablet-based multimedia education in clinic

standard of care provider led education

Group Type ACTIVE_COMPARATOR

standard of care provider led education

Intervention Type OTHER

Participants will receive standard of care education from their provider

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

text-based education messages only

Participants will receive text-based education messages

Intervention Type OTHER

in-clinic tablet-based multimedia education

Participants will receive tablet-based multimedia education in clinic

Intervention Type OTHER

standard of care provider led education

Participants will receive standard of care education from their provider

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* a known pediatric cancer diagnosis
* Adult caregivers of children with cancer (\<18yo) at time of new patient registration
* Ability to understand and speak Swahili
* If illiterate, availability of a household member who can read Swahili
* Be able to access the messages

Exclusion Criteria

* any potential participant who is unable to access messages will also be excluded.
* Non cancer pediatric diagnosis
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

Duke University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kristin Schroeder Principal Investigator

Role: PRINCIPAL_INVESTIGATOR

Duke University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hillary Sued Study Coordinator

Role: CONTACT

+255 785 808 594

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R21CA284299-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

Pro00115965

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cancer Care Companion
NCT07278778 NOT_YET_RECRUITING NA
Digital Self-Management and Peer Mentoring Intervention
NCT06763770 ENROLLING_BY_INVITATION NA